Besides, ascorbate is selectively taken up by cancer cells, including GBM [73], due to overexpression of glucose transporters GLUT1, SVCT1, and SVCT2 [74], thus enabling vigorous in situ ascorbate-driven menadione redox cycling in transformed cells. This evidence concerns the gene SLC23A1 and glioblastoma.